EUVIMEDEUVIMED entdecken
Querschnittstudie

HLA Allele Distribution in Patients with End-Stage Renal Disease: A Cross-Sectional Study

Süleyman Rüştü Oğuz, Ayşe Sinangil, Demet Kıvanç, Hayriye Şentürk Çiftçi, Mehmet Güven Günver, Barış Akın, Alaattin Yıldız

Turkish Journal of Immunology · 13.07.2026

DOI: 10.36519/tji.2026.pp4 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Turkish Journal of Immunology, online erschienen am 13.07.2026. Verfasst von Süleyman Rüştü Oğuz und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our study was conducted to analyze the association between HLA polymorphism and end stage renal disease (ESRD) in patients and to determine the underlying mechanisms of the onset and progression of renal failure. Materials and Methods: In our study we included 120 patients on the kidney transplant waiting list and 100 unrelated donors who underwent HLA typing using the polymerase chain reaction-sequence specific primer (SSP) method at the Tissue Typing Laboratory of Demiroğlu Bilim University Gayrettepe Florence Nightingale Hospital in between 2021-2023. The frequencies of HLA-A,-B,-DRB1 alleles were compared between ESRD patients and the control group, and the relationship between ESRD risk factors, HLA allele frequency (AF), haplotype frequency (HF) was investigated.

Results

Similar alleles were observed at high frequencies in both the ESRD patient and control groups, with these alleles which are HLA-A*02 (0.239/0.245), HLA-B*35 (0.225/0.183), and HLA-DRB1*11 (0.230/0.216). The most common haplotypes in patients were A*24~B*35~DR*11 (0.0495), A*02~B*51~DR*11 (0.0485), A*03~B*44~DR*04 (0.0270), A*11~B*35~DR*01 (0.0225), A*02~B*35~DR*04 (0.0225), while in controls they were A*24~B*35~DR*11 (0.0231), A*23~B*49~DR*11 (0.0192), A*02~B*51~DR*13 (0.0179), A*03~B*18~DR*11 (0.0149), A*02~B*18~DR*04 (0.0142) in the controls. For the HLA-B locus, the risk factors were B*50 (p:0.017), B*51 (p

Zitieren

APA

Oğuz, S. R., Sinangil, A., Kıvanç, D., Çiftçi, H. Ş., Günver, M. G., Akın, B., & Yıldız, A. (2026). HLA Allele Distribution in Patients with End-Stage Renal Disease: A Cross-Sectional Study. Turkish Journal of Immunology. https://doi.org/10.36519/tji.2026.pp4

Vancouver

Oğuz SR, Sinangil A, Kıvanç D, Çiftçi HŞ, Günver MG, Akın B, et al. HLA Allele Distribution in Patients with End-Stage Renal Disease: A Cross-Sectional Study. Turkish Journal of Immunology. 2026. doi:10.36519/tji.2026.pp4

BibTeX
@article{Ouz2026,
  author = {Oğuz, Süleyman Rüştü and Sinangil, Ayşe and Kıvanç, Demet and Çiftçi, Hayriye Şentürk and Günver, Mehmet Güven and Akın, Barış and Yıldız, Alaattin},
  title = {HLA Allele Distribution in Patients with End-Stage Renal Disease: A Cross-Sectional Study},
  journal = {Turkish Journal of Immunology},
  year = {2026},
  doi = {10.36519/tji.2026.pp4}
}
Kostenlos starten →